Home/Filings/4/0001140361-23-004732
4//SEC Filing

Schorno Dean L 4

Accession 0001140361-23-004732

CIK 0001034842other

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 5:40 PM ET

Size

4.4 KB

Accession

0001140361-23-004732

Insider Transaction Report

Form 4
Period: 2023-02-02
Schorno Dean L
EVP & Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2023-02-02$1.66/sh5,389$8,946196,519 total
Footnotes (1)
  • [F1]These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.

Documents

1 file

Issuer

RIGEL PHARMACEUTICALS INC

CIK 0001034842

Entity typeother

Related Parties

1
  • filerCIK 0001509688

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 5:40 PM ET
Size
4.4 KB